Literature DB >> 25341581

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors).

Philipp Harter1, David Gershenson, Catherine Lhomme, Fabrice Lecuru, Jonathan Ledermann, Diane M Provencher, Delia Mezzanzanica, Michael Quinn, Johanna Maenpaa, Jae-Weon Kim, Sven Mahner, Felix Hilpert, Klaus Baumann, Jacobus Pfisterer, Andreas du Bois.   

Abstract

Since the early 1970s, the World Health Organization and the International Federation of Gynecology and Obstetrics have classified borderline ovarian tumors as an independent group of ovarian epithelial tumors. A consensus statement of the Gynecologic Cancer Intergroup is reported.

Entities:  

Mesh：

Year:  2014        PMID： 25341581     DOI： 10.1097/IGC.0000000000000282

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN： 1048-891X            Impact factor:   3.437


  21 in total

1.  Oocyte cryopreservation in two women with borderline ovarian tumor recurrence.

Authors:  Francesca Filippi; Fabio Martinelli; Edgardo Somigliana; Dorella Franchi; Francesco Raspagliesi; Valentina Chiappa
Journal:  J Assist Reprod Genet       Date:  2020-03-04       Impact factor: 3.412

2.  Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell lines.

Authors:  Marta Llauradó Fernández; Gabriel E DiMattia; Amy Dawson; Sylvia Bamford; Shawn Anderson; Bryan T Hennessy; Michael S Anglesio; Trevor G Shepherd; Clara Salamanca; Josh Hoenisch; Anna Tinker; David G Huntsman; Mark S Carey
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

3.  Management of Borderline Ovarian Tumors-Still a Gray Zone.

Authors:  Nidhi Nayyar; Prerna Lakhwani; Ashish Goel; Pankaj Kr Pande; Kapil Kumar
Journal:  Indian J Surg Oncol       Date:  2017-08-25

4.  Accuracy of Intraoperative Frozen Section Diagnosis of Borderline Ovarian Tumors by Hospital Type.

Authors:  Jaimin S Shah; Michael Mackelvie; David M Gershenson; Preetha Ramalingam; Marylee M Kott; Jubilee Brown; Polly Gauthier; Elizabeth Nugent; Lois M Ramondetta; Michael Frumovitz
Journal:  J Minim Invasive Gynecol       Date:  2018-04-19       Impact factor: 4.137

5.  Ovarian mucinous borderline tumor with anaplastic carcinomatous nodules in adolescents.

Authors:  Mengqi Huang; Qian Lv; Jingyan Xie
Journal:  J Ovarian Res       Date:  2022-07-14       Impact factor: 5.506

6.  Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer.

Authors:  Irma Virant-Klun; Martin Stimpfel
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

7.  Borderline tumors of the ovary: A clinicopathological study.

Authors:  Samia Yasmeen; Abdul Hannan; Fareeha Sheikh; Amir Ali Syed; Neelam Siddiqui
Journal:  Pak J Med Sci       Date:  2017 Mar-Apr       Impact factor: 1.088

8.  Risk of synchronous endometrial disorders in women with endometrioid borderline tumors of the ovary.

Authors:  Shuang-Zheng Jia; Jun-Ji Zhang; Jun-Jun Yang; Yang Xiang; Zhiyong Liang; Jin-Hua Leng
Journal:  J Ovarian Res       Date:  2018-04-19       Impact factor: 4.234

Review 9.  Fertility Preservation: A Key Survivorship Issue for Young Women with Cancer.

Authors:  Ana Milena Angarita; Cynae A Johnson; Amanda Nickles Fader; Mindy S Christianson
Journal:  Front Oncol       Date:  2016-04-25       Impact factor: 6.244

10.  Diagnostic workup for endometrioid borderline ovarian tumors (eBOT) requires histopathological evaluation of the uterus.

Authors:  Juliane Reichenbach; Elisa Schmoeckel; Sven Mahner; Fabian Trillsch
Journal:  J Ovarian Res       Date:  2021-07-07       Impact factor: 4.234
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.